/
Other
Clinical Trial
133
Pipeline Programs↗
133
Active Trials↗
153
Companies Involved↗
Clinical Trial is a highly competitive landscape with 133 programs across 153 companies. The most active players are Daewon Pharmaceutical Co., Ltd., SUNHO（China）BioPharmaceutical CO., Ltd., Merck & Co.. 28 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical31
Phase 142
Phase 232
Phase 328
Approved
No programs
Analysis
Modality Breakdown
86%
Small molecule
99 of 115 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 115 classified programs, each share of the total. Modality classified for 100% of 133 pipeline programs.
Analysis
Trial Status
873
clinical trials
Completed518 · 59%
Unknown status158 · 18%
Recruiting59 · 7%
Terminated39 · 4%
Active, not recruiting33 · 4%
Not yet recruiting32 · 4%
Other34 · 4%
Clinical Trials
Trial Activity
873 trials
A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL
Recruiting·TThe First Affiliated Hospital with Nanjing Medical University·Phase 3·NCT05931263·104 enrolled
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Recruiting·—·N/A·NCT05391126·178 enrolled
A Phase Ia Clinical Trial of HW241045
Recruiting·HHubei Bio-Pharmaceutical Industrial Technological Institute Inc.·Phase 1·NCT07448194·56 enrolled
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
Recruiting·—·Phase 2·NCT04341181·300 enrolled
Page 1 of 59
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)